Postoperative radiotherapy improves disease-free survival of EGFR wild-type pN2 non-squamous-cell non-small-cell lung cancer (Nsq-NSCLC) patients after complete resection: a propensity score matching analysis
For patients with completely resected pN2 Nsq-NSCLC receiving adjuvant chemotherapy, PORT may improve DFS in EGFRwt patients but not in EGFRm patients. Randomized clinical trials are needed for validation.
Authors
- Zhouguang Hui (ORCID: https://orcid.org/0000-0002-7189-4692)
- Jianyang Wang (ORCID: https://orcid.org/0000-0001-9263-8914)
- Lühua Wang (ORCID: https://orcid.org/0000-0002-5272-1681)
- Shuang Sun (ORCID: https://orcid.org/0000-0002-1274-0087)
- Yunsong Liu (ORCID: https://orcid.org/0000-0001-8364-1898)
- Zeliang Ma (ORCID: https://orcid.org/0000-0001-8250-0540)
- Yu Men (ORCID: https://orcid.org/0000-0001-6956-7425)
- Lei Deng (ORCID: https://orcid.org/0000-0001-5919-5074)
- Nan Bi (ORCID: https://orcid.org/0000-0001-7201-2930)
- Wenqing Wang (ORCID: https://orcid.org/0000-0002-6710-4045)
- Yang Wang (ORCID: https://orcid.org/0000-0002-0078-8585)
- Xu Yang (ORCID: https://orcid.org/0000-0002-5752-7255)
- Yongxing Bao (ORCID: https://orcid.org/0000-0002-4178-4046)
- Yirui Zhai
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Lancaster University (GB)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1186/s13014-025-02592-0
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Beijing Xisike Clinical Oncology Research Foundation